ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92 | -10.7% | 45,246 | +1.1% | 0.00% | – |
| Q2 2023 | $103 | -24.3% | 44,773 | -0.3% | 0.00% | – |
| Q1 2023 | $136 | -22.7% | 44,893 | -40.5% | 0.00% | – |
| Q4 2022 | $176 | -99.9% | 75,406 | -0.1% | 0.00% | – |
| Q3 2022 | $144,000 | -29.4% | 75,476 | +0.5% | 0.00% | – |
| Q2 2022 | $204,000 | +106.1% | 75,132 | +126.2% | 0.00% | – |
| Q1 2022 | $99,000 | -23.3% | 33,217 | +0.1% | 0.00% | – |
| Q4 2021 | $129,000 | -9.8% | 33,176 | -0.4% | 0.00% | – |
| Q3 2021 | $143,000 | -29.6% | 33,322 | -50.2% | 0.00% | – |
| Q2 2021 | $203,000 | +130.7% | 66,900 | +173.1% | 0.00% | – |
| Q1 2019 | $88,000 | -6.4% | 24,500 | 0.0% | 0.00% | – |
| Q4 2018 | $94,000 | -59.5% | 24,500 | 0.0% | 0.00% | – |
| Q3 2018 | $232,000 | +29.6% | 24,500 | 0.0% | 0.00% | – |
| Q2 2018 | $179,000 | – | 24,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
| RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
| A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
| Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
| Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
| FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
| Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
| LMR Partners LLP | 107,912 | $196,000 | 0.01% |
| Virtu Financial LLC | 17,147 | $31,000 | 0.00% |